Tadalafil
Tadalafil is a prescription medication used to treat erectile dysfunction in men by increasing blood flow to the penis. It is also prescribed for pulmonary arterial hypertension and benign prostatic hyperplasia. Available as oral tablets in strengths of 2.5 mg, 5 mg, 10 mg, and 20 mg, manufactured by Qilu Pharmaceutical Co., Ltd. and Upsher-Smith Laboratories, LLC. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Tadalafil is a prescription medication used to treat erectile dysfunction in men by increasing blood flow to the penis. It is also prescribed for pulmonary arterial hypertension and benign prostatic hyperplasia. Available as oral tablets in strengths of 2.5 mg, 5 mg, 10 mg, and 20 mg, manufactured by Qilu Pharmaceutical Co., Ltd. and Upsher-Smith Laboratories, LLC. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Tadalafil",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Tadalafil — ANDA 208934 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208934"
}
]
|
| identifier | ANDA208934 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"fda",
"medications",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Tadalafil |
